Remove Healthcare Remove Manufacturing Remove Physicians Remove Prescription
article thumbnail

Use Your Physician Directory to Increase Patient Conversion

LEVO Health

Pharmaceutical brands often take a backseat role in patient health by encouraging patients to talk to their healthcare provider about treatment options. However, today’s healthcare consumers are asking for a different approach. One way to do this is through a physician directory. Capitalizing on the Retail Experience.

article thumbnail

Consequences of the First 10 Drugs Selected for Medicare’s Negotiation Program

PM360

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. CMS will present an initial offer for each drug’s maximum fair price (MFP) by February 1, 2024.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Addressing the Polypharmacy Problem

PM360

If one of those conditions is type 2 diabetes, that person may be taking seven prescription medications, 1 managing two or more additional chronic conditions, 2 and paying $13,000 per year on healthcare. senior adults (aged 65+) 7 taking five or more prescription medications. 3 They are also 2.6 In the U.S.,

article thumbnail

ELITE 2023 Digital Crusader Karina Castagna of OptimizeRx

PM360

Ultimately, she helps industry utilize technology that connects the ecosystem from the manufacturer, pharmacy, hub, and payer to bring therapies to patients. Karina joined OptimizeRx in 2021, where she has increased the digitalization of access to help move drug manufacturers away from manual processes.

article thumbnail

Five points on CMS’s first ten picks for price negotiations

Clarivate

While more expensive than type 2 diabetes drugs, blood thinners follow a similar pattern of high prescription volumes. In both cases, a shift in formulary placement could lower prescription volumes and reduce member utilization. With 27.5% exclusions exist for orphan drug designation and biosimilar competition ).

article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

One reason for this growth is an increasing demand for personalized healthcare technologies as patients look for advances in how healthcare is delivered following the pandemic. Unlike other formulary optimization solutions, Levrx delivers plan-specific and real-time prescription insights. billion in 2030 at a CAGR of 9.2%.

article thumbnail

Prescribing shift for Pfizer’s Paxlovid expands access but draws questions

Pharmaceutical Technology

Previously, only licensed and authorised physicians, advanced practice registered nurses, and physician assistants could prescribe the drug. . They will [check] new prescriptions for appropriateness and accuracy and that doesn't really change based on who's prescribing it.”. How to get Paxlovid.